glp 1 with kidney disease GLP-1s lower BMI, preserve function for adults diabetes post- kidney transplant Renal effects of GLP-1 receptor

Several peer-reviewed case reports have reported associations of Melanotan-2 with melanoma or nevocytic changes

Eluxadoline (Viberzi) is a mixed opioid receptor agonist and antagonist approved for the treatment of diarrhea-predominant IBS (IBS-D), although it is contraindicated in individuals who do not have a gallbladder and have a history of biliary disorders, pancreatitis, or alcohol use disorder, among other things

This isnt a school science experiment

The program targets adults who meet medical criteria for GLP-1 medications, typically those with a BMI of 30 or higher or 27+ with weight-related health conditions, and who want more support than a prescription alone

doi:10.1080/02699052.2019.1587000 198

Adair JC, Knoefel JE, Morgan N